. 2015 Sep 23;4(2):197–201. doi: 10.1007/s40119-015-0050-2

Table 2.

Admission and discharge antithrombotic regimens in patients undergoing transcatheter aortic valve replacement

Admission antithrombotic regimen	Discharge antithrombotic regimen
Admission antithrombotic regimen	SAPT^a	DAPT^b	OAC	SAPT + OAC	Triple^c	Died	Total
None	4	16	0	4	1	5	30
SAPT	7	78	0	16	0	3	104
DAPT	1	21	0	4	1	2	29
OAC	0	1	2	21	7	2	33
SAPT + OAC	0	5	0	43	3	3	54
Triple	0	1	0	1	3	0	5
Total	12	122	2	89	15	15	255

ASA aspirin (acetylsalicylic acid), DAPT dual antiplatelet therapy, OAC oral anticoagulation, SAPT single antiplatelet therapy

^aSAPT = ASA or P2Y12 antagonist

^bDAPT = ASA + P2Y12 antagonist

^cTriple = ASA + P2Y12 antagonist + OAC